Friday, July 10, 2026

pharma · Extensive-stage Small Cell Lung Cancer · Gastric Cancer

Shanghai Medical College

Shanghai Medical College clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
20 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
20
Programs
4
Drugs
3
Patents
0
Intelligence · Clinical Programs

Shanghai Medical College projects

1 ClinicalTrials.gov programs sponsored by Shanghai Medical College.

Shanghai Medical College has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. tissue-of-origin (ORIGIN-PanCA○R) profiling

    Fudan University

    Cancer of Unknown Primary Site

    phase 3 gene therapy completed

    1 trial

Frequently asked questions

How many clinical projects does Shanghai Medical College have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.